Cargando…
Precision Medicine: An Optimal Approach to Patient Care in Renal Cell Carcinoma
Renal cell cancer (RCC) is a heterogeneous tumor that shows both intra- and inter-heterogeneity. Heterogeneity is displayed not only in different patients but also among RCC cells in the same tumor, which makes treatment difficult because of varying degrees of responses generated in RCC heterogeneou...
Autores principales: | Sharma, Revati, Kannourakis, George, Prithviraj, Prashanth, Ahmed, Nuzhat |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9237320/ https://www.ncbi.nlm.nih.gov/pubmed/35775004 http://dx.doi.org/10.3389/fmed.2022.766869 |
Ejemplares similares
-
Determinants of resistance to VEGF-TKI and immune checkpoint inhibitors in metastatic renal cell carcinoma
por: Sharma, Revati, et al.
Publicado: (2021) -
In Vitro and In Silico Analysis of Epithelial-Mesenchymal Transition and Cancer Stemness as Prognostic Markers of Clear Cell Renal Cell Carcinoma
por: Sharma, Revati, et al.
Publicado: (2023) -
Aberrant pregnancy-associated plasma protein-A expression in breast cancers prognosticates clinical outcomes
por: Prithviraj, Prashanth, et al.
Publicado: (2020) -
Prognostic Role of Immune Checkpoint Regulators in Cholangiocarcinoma: A Pilot Study
por: Cao, Lu, et al.
Publicado: (2021) -
Crosstalk between Immune Checkpoint Modulators, Metabolic Reprogramming and Cellular Plasticity in Triple-Negative Breast Cancer
por: Poddar, Arpita, et al.
Publicado: (2022)